Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking. This study aimed to assess the efficacy of ziprasidone plus sertraline in TRS patients as compared to ziprasidone monoth...
Saved in:
Main Authors: | Hui Shi (Author), Jing Xu (Author), Xiaoe Lang (Author), Hanjing Emily Wu (Author), Mei Hong Xiu (Author), Xiang Yang Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ziprasidone in the Treatment of Delusional Parasitosis
by: P. Contreras-Ferrer, et al.
Published: (2012) -
Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia
by: Xiaoe Lang, et al.
Published: (2023) -
Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
by: Seema M. Patel, PharmD, BCPP, et al.
Published: (2021) -
Parenteral Sustained Release Lipid Phase-Transition System of Ziprasidone: Fabrication and Evaluation for Schizophrenia Therapy
by: Khan UA, et al.
Published: (2020) -
Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl
by: Sathis Kumar Dinakaran, et al.
Published: (2011)